We are live on ! Find out more
HSACU

Health Sciences Acquisitions Corporation Units
HSACU

Delisted

HSACU was delisted on the 18th of December, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Health Sciences Acquisitions Corporation Units in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 24 → 0 (-24)

100% less capital invested

Capital invested by funds: $62.9M → $0 (-$62.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 24

Holders
–
Holders Change
-24
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$11.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.9M
3
EAM
Eventide Asset Management
Massachusetts
-$7.3M
4
MIM
Monashee Investment Management
Massachusetts
-$4.56M
5
PA
Perceptive Advisors
New York
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
– -$11.6M -1,080,000 Closed
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
– -$10.9M -1,020,000 Closed
EAM
3
Eventide Asset Management
Massachusetts
– -$7.3M -680,000 Closed
MIM
4
Monashee Investment Management
Massachusetts
– -$4.56M -425,000 Closed
PA
5
Perceptive Advisors
New York
– -$4.29M -400,000 Closed
PAMP
6
Polar Asset Management Partners
Ontario, Canada
– -$4.02M -375,000 Closed
SCM
7
Sio Capital Management
New York
– -$3.29M -307,000 Closed
HCM
8
Highline Capital Management
New York
– -$3.01M -280,371 Closed
PC
9
Periscope Capital
Ontario, Canada
– -$2.43M -226,300 Closed
KPF
10
K2 Principal Fund
Ontario, Canada
– -$2.27M -211,500 Closed
BCM
11
Basso Capital Management
Connecticut
– -$1.1M -102,489 Closed
BFM
12
Boothbay Fund Management
New York
– -$1.07M -100,000 Closed
RCM
13
Rivernorth Capital Management
Florida
– -$1.07K -100,000 Closed
SFM
14
Sphera Funds Management
Israel
– -$1.07M -100,000 Closed
VOAM
15
Vertex One Asset Management
British Columbia, Canada
– -$1.07M -100,000 Closed
Walleye Trading
16
Walleye Trading
New York
– -$989K -92,153 Closed
MF
17
Magnetar Financial
Illinois
– -$943K -87,900 Closed
Walleye Capital
18
Walleye Capital
New York
– -$913K -85,100 Closed
SSA
19
Schonfeld Strategic Advisors
New York
– -$912K -85,000 Closed
WAM
20
Wolverine Asset Management
Illinois
– -$700K -65,253 Closed
UBS Group
21
UBS Group
Switzerland
– -$164K -15,308 Closed
CAC
22
Cowen and Company
New York
– -$135K -12,572 Closed
HIM
23
HGC Investment Management
Ontario, Canada
– -$84K -7,740 Closed
TRCT
24
Tower Research Capital (TRC)
New York
– -$1K -76 Closed

HSACU Hedge Fund Activity: Q4 2019 in Review

0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Health Sciences Acquisitions Corporation Units (HSACU) for Q4 2019, worth a combined $0 — down 100% from $62.9M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of HSACU and 0 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $11.6M sold.

  • 0 institutional investors held Health Sciences Acquisitions Corporation Units (HSACU) as of Q4 2019, down from 24 in Q3 2019.
  • Funds reported $0 of Health Sciences Acquisitions Corporation Units stock for Q4 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Health Sciences Acquisitions Corporation Units positions in Q4 2019 and 24 closed out, a net change of -24 holders.
  • The largest Health Sciences Acquisitions Corporation Units seller in Q4 2019 was Cormorant Asset Management, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2019.